National Association of Medical Examiners Position Paper: Retaining Postmortem Samples for Genetic Testing. Issue 2 (June 2013)

• Record Type: Journal Article
• Authors: Middleton, Owen; Baxter, Samantha; Demo, Erin; Honeywell, Christina; Jentzen, Jeff; Miller, Frank; Pinckard, J. Keith; Reichard, R. Ross; Rutberg, Julie; Stacy, Carl; MacLeod, Heather
• Is Part Of: Academic forensic pathology. Volume 3:Issue 2(2013)
• Page Start: 191
• Page End: 194
• Publication Date: 2013-06
• Subjects: Forensic pathology -- Autopsy -- Postmortem samples -- Genetic testing -- Death investigation; Forensic pathology -- Periodicals; Forensic pathology; Electronic journals; Periodicals; 614.1
• DOI: 10.23907/2013.024
• Languages: English
• ISSNs: 1925-3621

Abstract

Sudden unexpected death is typically diagnosed in infants, children, teenagers, and young adults following completion of an autopsy that fails to identify a cause of death or when autopsy suggests a potentially genetic cause of death in an individual less than 40, such as cardiomyopathy or aneurysm. Such deaths may be a result of genetic abnormalities that are unable to be diagnosed by gross or microscopic inspection, but may be detectable by molecular studies. Unfortunately, the ability to perform postmortem genetic testing is frequently hindered by lack of an appropriate specimen following completion of an autopsy. This paper provides recommendations developed by the National Association of Medical Examiners with the assistance of genetic counselors. The recommendations establish procedures to facilitate postmortem genetic testing and DNA banking by health care professionals assisting families who have experienced sudden death in young relatives by clarifying proper sample acquisition and storage. Additionally, recommendations for discussion with surviving family members and test planning are provided. The objective of these recommendations is to ensure that postmortem samples suitable for DNA banking are retained, allowing at risk family members improved detection of potentially treatable genetic diseases.